欧洲α-1研究协作组（EARCO）在葡萄牙的实施：未来从现在开始。 - Suppr | 超能文献

Implementation of European Alpha-1 Research Collaboration (EARCO) in Portugal: the future starts now.

作者信息

Sucena M, Gomes J, Guimarães C, Miravitlles M

机构信息

Pulmonology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.

Pulmonology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.

出版信息

Pulmonology. 2020 Jul-Aug;26(4):181-183. doi: 10.1016/j.pulmoe.2020.01.003. Epub 2020 Feb 10.

DOI:10.1016/j.pulmoe.2020.01.003

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Implementation of European Alpha-1 Research Collaboration (EARCO) in Portugal: the future starts now.欧洲α-1研究协作组（EARCO）在葡萄牙的实施：未来从现在开始。

Pulmonology. 2020 Jul-Aug;26(4):181-183. doi: 10.1016/j.pulmoe.2020.01.003. Epub 2020 Feb 10.

2

Spanish Implementation of the New International Alpha-1 Anitrypsin Deficiency International Registry: The European Alpha-1 Research Collaboration (EARCO).新国际α-1抗胰蛋白酶缺乏症国际登记处的西班牙实施情况：欧洲α-1研究协作组（EARCO）

Arch Bronconeumol (Engl Ed). 2021 Feb;57(2):81-82. doi: 10.1016/j.arbres.2020.02.003. Epub 2020 Mar 18.

3

Regulation of clinical research and bioethics in Portugal.葡萄牙的临床研究与生物伦理规范。

Bioethics. 2007 Jun;21(5):290-302. doi: 10.1111/j.1467-8519.2007.00555.x.

4

Collaboration: a SWOT analysis of the process of conducting a review of nursing workforce policies in five European countries.协作：对五个欧洲国家护理人员政策审查过程的SWOT分析

J Nurs Manag. 2014 May;22(4):485-98. doi: 10.1111/j.1365-2834.2012.01466.x. Epub 2012 Nov 2.

5

Migrants' access to healthcare services within the European Union: a content analysis of policy documents in Ireland, Portugal and Spain.欧盟内部移民获得医疗保健服务的情况：对爱尔兰、葡萄牙和西班牙政策文件的内容分析。

Global Health. 2018 Jun 15;14(1):57. doi: 10.1186/s12992-018-0373-6.

6

A new interministerial strategy for the promotion of healthy eating in Portugal: implementation and initial results.葡萄牙促进健康饮食的新部际战略：实施与初步成果。

Health Res Policy Syst. 2018 Oct 30;16(1):102. doi: 10.1186/s12961-018-0380-3.

7

[The pharmacovigilance system in Portugal (its establishment and development)].

Cad Saude Publica. 1998 Oct-Dec;14(4):725-33. doi: 10.1590/s0102-311x1998000400014.

8

[Scientific Research Policy for Health in Portugal: I - European and National Environment].[葡萄牙卫生科研政策：一、欧洲和国家环境]

Acta Med Port. 2017 Feb 27;30(2):141-147. doi: 10.20344/amp.8011.

9

Highlights of PBTI Coimbra Conference on PRT of Plasma & Current Opinions on Pathogen Reduction Treatment of Blood Components.波尔图大学科英布拉医学院关于血浆病原体减少技术（PRT）会议亮点及血液成分病原体减少治疗的当前观点

Transfus Apher Sci. 2015 Apr;52(2):228-32. doi: 10.1016/j.transci.2015.02.010. Epub 2015 Feb 14.

10

[Scientific Research Policy for Health in Portugal: II - Facts and Suggestions].[葡萄牙卫生科研政策：II - 事实与建议]

Acta Med Port. 2017 Mar 31;30(3):233-242. doi: 10.20344/amp.8012.

引用本文的文献

1

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.α-1 抗胰蛋白酶缺乏个体的临床和功能特征：EARCO 国际登记处。

Respir Res. 2022 Dec 16;23(1):352. doi: 10.1186/s12931-022-02275-4.

2

Demographic and clinical characteristics of patients with α-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO.西班牙EARCO登记处中α-抗胰蛋白酶缺乏基因型PI*ZZ和PI*SZ患者的人口统计学和临床特征。

ERJ Open Res. 2022 Sep 26;8(3). doi: 10.1183/23120541.00213-2022. eCollection 2022 Jul.